These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36407415)

  • 1. Pathogenic variants of the
    Ohata Y; Kakimoto H; Seki Y; Ishihara Y; Nakano Y; Yamamoto K; Takeyari S; Fujiwara M; Kitaoka T; Takakuwa S; Kubota T; Ozono K
    Bone Rep; 2022 Dec; 17():101637. PubMed ID: 36407415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental Origin of
    McMullan P; Maye P; Yang Q; Rowe DW; Germain-Lee EL
    JBMR Plus; 2022 Jan; 6(1):e10570. PubMed ID: 35079678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Definition of Pseudohypoparathyroidism Variants.
    Jüppner H
    J Clin Endocrinol Metab; 2021 May; 106(6):1541-1552. PubMed ID: 33529330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypoparathyroidism: one gene, several syndromes.
    Tafaj O; Jüppner H
    J Endocrinol Invest; 2017 Apr; 40(4):347-356. PubMed ID: 27995443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.
    Hanna P; Grybek V; Perez de Nanclares G; Tran LC; de Sanctis L; Elli F; Errea J; Francou B; Kamenicky P; Linglart L; Pereda A; Rothenbuhler A; Tessaris D; Thiele S; Usardi A; Shoemaker AH; Kottler ML; Jüppner H; Mantovani G; Linglart A
    J Bone Miner Res; 2018 Aug; 33(8):1480-1488. PubMed ID: 29693731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.
    Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1a.
    Itoh M; Okajima M; Kittaka Y; Yachie A; Wada T; Saikawa Y
    Bone Rep; 2022 Jun; 16():101569. PubMed ID: 35497370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.
    Turan S; Thiele S; Tafaj O; Brix B; Atay Z; Abali S; Haliloglu B; Bereket A; Bastepe M
    Bone; 2015 Feb; 71():53-7. PubMed ID: 25464124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Transmission Ratio Distortion of GNAS Loss-of-Function Mutations.
    Snanoudj S; Molin A; Colson C; Coudray N; Paulien S; Mittre H; Gérard M; Schaefer E; Goldenberg A; Bacchetta J; Odent S; Naudion S; Demeer B; Faivre L; Gruchy N; Kottler ML; Richard N
    J Bone Miner Res; 2020 May; 35(5):913-919. PubMed ID: 31886927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragenic Deletions of GNAS in Pseudohypoparathyroidism Type 1A Identify a New Region Affecting Methylation of Exon A/B.
    Li D; Bupp C; March ME; Hakonarson H; Levine MA
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3197-206. PubMed ID: 32436958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in pseudohypoparathyroidism 1a and pseudopseudohypoparathyroidism in ethnic Chinese.
    Wu YL; Hwang DY; Hsiao HP; Ting WH; Huang CY; Tsai WY; Chen HC; Chao MC; Lo FS; Tsai JD; Yang S; Shih SL; Lin SP; Lin CL; Lee YJ
    PLoS One; 2014; 9(3):e90640. PubMed ID: 24651309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.
    Lemos MC; Thakker RV
    Hum Mutat; 2015 Jan; 36(1):11-9. PubMed ID: 25219572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different AHO phenotype in a Chinese family with a novel GNAS missense variant: a case report.
    Zhou Q; Liang B; Fu QX; Liu H; Zou CC
    Ital J Pediatr; 2022 Jul; 48(1):123. PubMed ID: 35871092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel
    Sano S; Iwamoto S; Matsushita R; Masunaga Y; Fujisawa Y; Ogata T
    Clin Pediatr Endocrinol; 2024; 33(2):66-70. PubMed ID: 38572379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
    Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
    Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNAS locus and pseudohypoparathyroidism.
    Bastepe M; Jüppner H
    Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.
    Chang G; Li Q; Li N; Li G; Li J; Ding Y; Huang X; Shen Y; Wang J; Wang X
    BMC Endocr Disord; 2022 Mar; 22(1):70. PubMed ID: 35296306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.
    Han SR; Lee YA; Shin CH; Yang SW; Lim BC; Cho TJ; Ko JM
    Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):118-125. PubMed ID: 31546270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.